BeOne Medicines AG (ONC) Financials: Revenue & Earnings
ONC$374.40+1.04 +0.28%
$40.01B
Market Cap
5.04
P/E
56.61
Forward P/E
—
Score
BeOne Medicines AG (ONC) Financials: Revenue & Earnings
ONC price $374.40 +1.04 +0.28%
- Ticker
- ONC
- Price
- $374.40
- Change
- +1.04 +0.28%
- Market cap ?
- $40.01B
- P/E ?
- 5.04
- Forward P/E ?
- 56.61
- Dividend yield ?
- 0.00%
- Beta ?
- 0.52
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1070000 | 238387000 | 198220000 | 428212000 | 308874000 | 1176283000 | 1415921000 | 2458779000 | 3810241000 | 5343033000 |
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid…
Earnings and financials
BeOne Medicines AG (ONC) trades at $374.40, with a market cap of $40.01B and a trailing P/E of 5.04. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1070000 | 238387000 | 198220000 | 428212000 | 308874000 | 1176283000 | 1415921000 | 2458779000 | 3810241000 | 5343033000 |
Insights · Dividends · Forecast · Financials · Learn